When I sit down with leadership teams, I frequently see cardiovascular events treated as isolated medical emergencies rather than structural operational failures. A heart attack or stroke rarely happens in a vacuum; left unmanaged, it triggers prolonged absence, reduced capacity, higher claims costs, early retirement, management disruption and the sudden loss of critical expertise. Yet many businesses still review cardiovascular risk as an afterthought tucked inside a generic wellbeing programme rather than treating it as a core indicator within their wider workforce risk framework.
What I see repeatedly is organisations treating this as a minor oversight when it is actually a strategic mistake. Heart health data belongs squarely in the end-of-quarter risk review because it can reveal emerging exposure long before that exposure ever surfaces in absence, insurance or productivity figures.
Cardiovascular risk is already a workforce issue
Cardiovascular disease is frequently dismissed as a later-life concern, but its employment impact begins much earlier in the career lifecycle. The Government's Get Britain Working White Paper reported that more than one in three heart attacks treated in hospital occurred in people of working age, while one in four people experiencing a stroke were also of working age. It also noted that more than 770,000 working-age adults with cardiovascular conditions were out of work, contributing approximately £1.2 billion in economic costs.
These figures demand a complete overhaul of how organisations frame the issue. Cardiovascular disease is not simply a clinical concern affecting a small number of older employees. It intersects directly with workforce participation, succession planning, absence management, occupational health, group risk and private medical insurance.
The wider scale is equally hard to ignore. The World Health Organisation identifies cardiovascular diseases as the leading cause of death globally, accounting for an estimated 17.9 million deaths each year. In the UK, the Office for National Statistics estimated that 148.9 million working days were lost because of sickness or injury in 2024, equivalent to 4.4 days per worker. The ONS figure does not isolate heart-related absence, but that is precisely why I advise leadership teams not to wait for absence data alone to expose the risk.
Absence is a lagging indicator. By the time a cardiovascular event appears in an absence report, the organisation has already incurred the operational and financial consequences.
The value lies in the pattern, not the individual record
The purpose of bringing heart health data into a risk review is never to police individual medical vulnerability. It is to understand patterns across the workforce and determine whether current controls are proportionate.
Useful data includes anonymised trends in blood pressure, cholesterol, diabetes risk, smoking status, physical activity, participation in cardiovascular screening, occupational health referrals and relevant absence patterns. When aggregated appropriately, these indicators help leadership teams ask much sharper operational questions.
Are particular sites, shifts or occupational groups showing higher levels of untreated risk? Are employees in safety-critical roles actually accessing health assessments? Are long working hours, sedentary work, travel demands or limited access to healthy food contributing to a preventable risk profile? Are health benefits reaching the groups most likely to experience barriers to care?
The NHS identifies smoking, physical inactivity, overweight, high blood pressure, high cholesterol and diabetes among the factors associated with cardiovascular disease. It also recognises that age, family history and ethnicity influence risk. A credible workforce review therefore distinguishes sharply between risks an employer can influence and characteristics it must accommodate fairly.
This distinction matters commercially. A high-level dashboard supports investment decisions; an employee-level dataset creates severe privacy, discrimination and trust risks if used without a clearly defined purpose.
Health intelligence should inform capital allocation
For Finance and Risk leaders, the case for reviewing heart health data is strongest when it is connected directly to capital allocation rather than presented as a standalone wellbeing metric.
If screening data indicates a concentration of elevated cardiovascular risk in a particular population, the appropriate response involves targeted health checks, improved access to occupational health, clinical referral pathways, smoking cessation support, better shift design or changes to the physical working environment. It also justifies a more detailed review of absence costs, income protection claims, life assurance experience and private medical insurance utilisation.
This is not an argument for treating employees as an insurance portfolio. It is an argument for using aggregated health intelligence to improve the organisation's understanding of foreseeable workforce exposure.
The Government's workplace cardiovascular health-check pilot illustrates this exact direction of travel. In 2024, the Department of Health and Social Care announced a programme intended to provide more than 130,000 workplace checks, recording information used to assess an individual's cardiovascular risk. The NHS Health Check programme is designed to identify behavioural and physiological risk factors early, before cardiovascular disease develops. Government guidance states that the programme aims to help prevent heart attacks and strokes, as well as detect diabetes and kidney disease.
For employers, the lesson is entirely practical: prevention is worthless unless it is linked to a structured route for follow-up. A screening exercise that produces data without clinical referral, employee communication or management accountability is not risk management. It is just expensive data collection.
The workforce context is more complex than wellbeing
Heart health must sit inside a broader review of work design and organisational health. The HSE estimated that 964,000 workers experienced work-related stress, depression or anxiety in 2024/25, resulting in 22.1 million working days lost. These conditions accounted for 52% of all work-related ill health and 62% of working days lost because of work-related ill health.
Stress is not equivalent to cardiovascular disease, and employers must avoid making simplistic causal claims. However, sustained pressure, poor recovery, inactivity and unhealthy coping behaviours sit squarely within the same organisational risk environment. A business that monitors mental health absence while ignoring the physical health profile of the workforce is reviewing only half the picture.
This breaks traditional HR strategy. A cardiovascular initiative built around individual responsibility alone will fail if the working environment makes healthy behaviour completely unrealistic. Organisations cannot offer a digital health app while demanding extended shifts, constant travel or zero predictable breaks. The more credible approach combines personal support with hard changes to work design, access and culture.
Data governance is part of the risk review
Heart health information is health data and therefore special category personal data under the UK GDPR. The Information Commissioner's Office states that organisations need both a lawful basis under Article 6 and an appropriate special category condition under Article 9 when processing workers' health information.
This requirement dictates how we design the review from day one. Organisations must define what they need to know, why they need it, who can access it and how long it will be retained. Individual clinical information must remain strictly with the appropriate healthcare provider or occupational health professional. Executive reporting must use anonymised, aggregated findings, with suppression controls where small populations could make individuals identifiable.
Trust is not an administrative afterthought. If employees believe that health data could influence promotion, redundancy, performance management or insurance decisions, participation will collapse and the data will become useless. The ICO emphasises that health information requires rigorous protection because inappropriate disclosure or use causes significant harm.
Four actions for the next review
First, treat cardiovascular health as a core workforce risk indicator rather than a seasonal campaign theme. Include it directly alongside absence, turnover, critical-role dependency, occupational health and benefits data.
Second, establish a minimum viable dashboard. Track participation in relevant screening, anonymised risk trends, referral completion, absence patterns and differences by site, role or working arrangement where sample sizes allow responsible analysis.
Third, connect every identified risk to a definitive intervention and owner. A rise in untreated hypertension must lead to a defined clinical referral route and an immediate assessment of whether access, scheduling or communication is creating operational friction.
Fourth, require a rigorous data-governance statement before collecting a single data point. The statement must specify the purpose, legal basis, access controls, aggregation rules and absolute separation between healthcare information and employment decisions.
Finally, review equity. Cardiovascular risk is shaped by socioeconomic circumstances, ethnicity, working conditions and access to care. A programme that primarily reaches senior office-based employees produces reassuring participation figures while leaving higher-risk groups completely exposed.
The end-of-quarter risk review exists to protect organisational resilience in the quarter ahead, not to audit what already went wrong in the last one. Heart health data provides an early view of workforce vulnerability, but only when it is handled ethically, interpreted in context and connected to decisive action. Stop counting health events after the damage is done. Use better intelligence to strip avoidable disruption from your balance sheet before it hits.